From the Journals

Cigarette smoking is associated with prefrontal function in patients with schizophrenia


 

FROM PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Patients with schizophrenia have decreased chronnectomic density in the dorsolateral prefrontal cortex, compared with healthy controls, and cigarette smoking in patients with schizophrenia may be associated with a degree of preserved function in that brain region, researchers reported. The results indicate that smoking may be associated with a preservation effect, but it “cannot restore patients’ prefrontal dysfunction to normal levels,” the researchers said.

The chronnectome depicts how brain functional connectivity patterns (i.e., the connectome) vary over time. Prior research has suggested that the chronnectome is altered in patients with schizophrenia and in people with nicotine addiction. “Therefore, the chronnectome may be an effective index to evaluate the smoking-related prefrontal functional changes in schizophrenia,” said Yun-Shuang Fan, a researcher at the Clinical Hospital of Chengdu Brain Science Institute in China, and colleagues in the report, which was published in Progress in Neuro-Psychopharmacology & Biological Psychiatry.

The investigators studied 49 patients with schizophrenia, including 22 smokers and 27 nonsmokers, and 43 healthy controls, including 22 smokers and 21 nonsmokers. Participants underwent resting-state functional magnetic resonance imaging, and the researchers analyzed chronnectomic density using a sliding-window method. The investigators examined interactions between smoking status and diagnosis.

Smoking was associated with reduced chronnectomic density in healthy controls, but increased density in patients with schizophrenia. The study provides a “framework to elaborate upon the self-medication hypothesis in schizophrenia” and sheds “some fresh light on the elevated rates of smoking in schizophrenia,” they said.

The study was relatively small, and patients’ use of antipsychotic medications, which can affect the connectome, may limit the results. In addition, the study’s cross-sectional design precludes knowing whether “smoking behavior is the cause or result of the prefrontal chronnectome alterations in schizophrenia,” the authors added.

The study was supported by the National Natural Science Foundation of China and the Sichuan Science and Technology Program. The researchers had no conflicts of interest.

SOURCE: Fan YS et al. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Apr 20. doi: 10.1016/j.pnpbp.2020.109860.

Recommended Reading

FDA approves Caplyta to treat schizophrenia in adults
MDedge Psychiatry
Antipsychotics, dopamine, and pain
MDedge Psychiatry
Half of SLE patients have incident neuropsychiatric events
MDedge Psychiatry
Top research findings of 2018-2019 for clinical practice
MDedge Psychiatry
Lumateperone for schizophrenia
MDedge Psychiatry
Therapeutic drug monitoring of antipsychotics
MDedge Psychiatry
FDA strengthens warning regarding clozapine, serious bowel complication risk
MDedge Psychiatry
Understanding postpartum psychosis: From course to treatment
MDedge Psychiatry
Cardiovascular disease risk higher in patients with schizophrenia, metabolic syndrome
MDedge Psychiatry
Early cognitive screening is key for schizophrenia spectrum disorder
MDedge Psychiatry